Skip to content
PIL Logo

Benepali 50 mg solution for injection in pre-filled pen

Last Updated on eMC 22-Aug-2017 View changes  | Biogen Idec Ltd Contact details

Black Triangle icon This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the link to the left to view the PIL in PDF format.

Certain risk materials on this website are intended for use by healthcare professionals only.

By proceeding you are confirming that you are a healthcare professional.

Want to avoid this message? If you are a Healthcare professional, REGISTER or LOGIN and you will not have to self-certify when you access Risk Minimisation Materials.

You can leave feedback on specific Risk Minimisation Materials or make general observations about how they are displayed on the eMC by leaving comments in the box below.

Please note that we are unable to respond to medical queries.

Benepali 50 mg solution for injection in pre-filled pen


Please enter your email address below

Tick here if you wish to recieve a response to your feedback

Risk Materials
VIEW

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Benepali Patient Alert Card

The PAC is located inside the Benepali box and should be carried by patients during treatment and for 2 months after the last dose.
The PAC contains the following key elements for patients treated with Benepali:
• The risk of opportunistic infections and tuberculosis (TB)
• The risk of Congestive Heart Failure (CHF).
• Benepali is not for use in children

Benepali Quick Reference Guide for Pre-filled Pen (PFPen EN v1.1)

Developed as a teaching guide for healthcare professionals to facilitate training of the patients in the safe use of the pre-filled pen.

For Healthcare Professionals
CLOSE THIS PANEL

Company contact details

Biogen Idec Ltd

Company image
Address

Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, UK

Medical Information Direct Line

+44 (0)203 608 8622

Out of Hours Telephone

+44 (0)203 608 8622

Telephone

+44 (0)203 608 8622

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

etanercept

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue